Gradient Biomodeling LLC
Gradient quantum similarity approach integrates fundamental knowledge from physics, chemistry and biology and translates it into meaningful drug leads.
Biomolecular interactions are quantum in nature. Gradient has developed and validated a computational platform for their theoretical modeling. The methodology is based on quantum representation of chemical structures and machine-learning fuzzy-decision algorithms, and takes advantage of the latest bioassay and biomedical big data developments. The technology has been successfully applied against a wide range of therapeutic targets.